Need for consensus when prescribing stereotactic body radiation therapy for prostate cancer

Int J Radiat Oncol Biol Phys. 2015 Jan 1;91(1):239-41. doi: 10.1016/j.ijrobp.2014.09.025.

Authors

David J Eaton¹, Olivia F Naismith², Ann M Henry³

Affiliations

¹ National Radiotherapy Trials QA Group, Mount Vernon Hospital, London, United Kingdom. Electronic address: davideaton@nhs.net.
² Department of Physics, Royal Marsden Hospital, Fulham Road, London, United Kingdom.
³ Department of Clinical Oncology, St. James's University Hospital, Leeds, United Kingdom.

PMID: 25835627
DOI: 10.1016/j.ijrobp.2014.09.025

No abstract available

MeSH terms

Consensus*
Humans
Male
Prostatic Neoplasms / surgery*
Radiosurgery / methods
Radiosurgery / standards*
Radiotherapy, Intensity-Modulated / methods
Radiotherapy, Intensity-Modulated / standards
Robotic Surgical Procedures / methods